All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IstaroximePST2744Phase 32 trials

    Windtree Therapeutics · Cardiogenic Shock

  • JAB-3312Phase 32 trials

    Allist Pharmaceuticals, Inc. · KRAS P.G12C, Non-small Cell Lung Cancer, Colorectal Cancer

  • JADE101Phase 32 trials

    Jade Biosciences, Inc. · IgA Nephropathy (IgAN), IgA Nephropathy

  • JK-1201IPhase 32 trials

    JenKem Technology Co., Ltd. · Glioblastoma Multiforme (GBM), Small Cell Lung Cancer

  • JMT103NarlumosbartPhase 32 trials

    Shanghai JMT-Bio Inc. · Giant Cell Tumor of Bone, Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors

  • JNJ-101556143Phase 32 trials

    Johnson & Johnson (Janssen) · Prostatic Neoplasms

  • JNJ-81201887AAVCAGsCD59Phase 32 trials

    Johnson & Johnson (Janssen) · Geographic Atrophy, Macular Degeneration

  • JNJ-90301900NBTXR3, Functionalized hafnium oxide nanoparticlesPhase 32 trials

    Johnson & Johnson (Janssen) · Carcinoma, Squamous Cell, Carcinoma, Non-Small-Cell Lung

  • JOINTSTEMPhase 32 trials

    R-Bio · Knee Osteoarthritis, Osteoarthritis, Knee

  • JS105Phase 32 trials

    Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors, Breast Cancer

  • JYP0322Phase 32 trials

    Guangzhou JOYO Pharma Co., Ltd · Non Small Cell Lung Cancer, NSCLC (Advanced Non-small Cell Lung Cancer)

  • KHN939Phase 32 trials

    Beijing Kanghong Biological Medicine Co., Ltd. · Thyroid Eye Disease

  • KITE-753Phase 32 trials

    Gilead Sciences · Relapsed or Refractory Large B-cell Lymphoma, Relapsed and/or Refractory B-cell Lymphoma

  • KLH-2109Phase 32 trials

    JW Pharmaceutical · Menorrhagia, Uterine Fibroids, Endometriosis

  • KPL-387Phase 32 trials

    Kiniksa Pharmaceuticals International, plc · Pericarditis, Recurrent Pericarditis, Pericarditis Acute

  • KSI-101tabirafuspPhase 32 trials

    Kodiak Sciences Inc · Macular Edema Secondary to Inflammation

  • KYV-101Phase 32 trials

    Kyverna Therapeutics · Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis

  • LAM561Phase 32 trials

    Laminar Pharmaceuticals · Primary Glioblastoma, Glioblastoma Multiforme, High-grade Glioma

  • LB1410Phase 32 trials

    L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer

  • LB4330Phase 32 trials

    L & L Bio Co., Ltd., Ningbo, China · Solid Tumor, Cervical Cancer

  • LepodisiranLY3819469Phase 32 trials

    Eli Lilly · Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)

  • linsitinibPhase 32 trials

    Sling Therapeutics, Inc. · Graves Orbitopathy, Thyroid Eye Disease, TED, Thyroid Eye Disease

  • Lower sulfate eye dropsLower sulfatePhase 32 trials

    Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Myopia

  • LucerastatPhase 32 trials

    Idorsia Pharmaceuticals Ltd. · Fabry Disease

  • matched to PregabalinPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • matched to semaglutidePhase 32 trials

    Novo Nordisk · Overweight, Obesity, Diabetes Mellitus, Type 2

  • matched to SUZPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • matched to zenagamtidePhase 32 trials

    Novo Nordisk · Overweight, Obesity

  • MC0518Phase 32 trials

    medac GmbH · Steroid-refractory Acute Graft-versus-host Disease

  • MCV4Phase 32 trials

    CanSino Biologics Inc. · Meningococcal Meningitis

  • Lupin Ltd. · Myotonic Dystrophy

  • MG1111BARICELA, Barycela inj.Phase 32 trials

    Green Cross Corporation · Varicella, Varicella (Chickenpox), Chickenpox Vaccine

  • MH004Phase 32 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Vitiligo, Atopic Dermatitis (AD)

  • MI078Phase 32 trials

    Nanjing Minova Pharmaceutical Co., Ltd. · Postpartum Depression (PPD), Postpartum Depression

  • MLC1501Phase 32 trials

    Moleac Pte Ltd. · Stroke, Stroke, Ischemic, Strokes Thrombotic

  • BioMarin · Achondroplasia

  • MosliciguatPhase 32 trials

    Pulmovant, Inc. · Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases

  • Mouthwash CPCPhase 32 trials

    Colgate Palmolive · Gingival Bleeding, Plaque Induced Gingival Disease, Gingivitis and Periodontal Diseases

  • MPSV4Phase 32 trials

    CanSino Biologics Inc. · Meningococcal Meningitis

  • Sanofi · Multiple Sclerosis

  • MTBVACBBV169Phase 32 trials

    Biofabri, S.L · Tuberculosis, Tuberculosis (TB)

  • nacubactamPhase 32 trials

    Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • NaporafenibLXH254, ERAS-254Phase 32 trials

    Novartis · Melanoma, Advanced or Metastatic NRAS-mutant Melanoma

  • NCX 470NCX 470 0.1%Phase 32 trials

    Nicox Ophthalmics, Inc. · Open Angle Glaucoma, Ocular Hypertension

  • NeladalkibNVL-655Phase 32 trials

    Nuvalent Inc. · Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive, Locally Advanced Solid Tumor

  • NeridronatePhase 32 trials

    Ambros Therapeutics, Inc. · Complex Regional Pain Syndrome Type I

  • NetakimabPhase 32 trials

    Biocad · Plaque Psoriasis

  • NH002Perflutren Lipid MicrospheresPhase 32 trials

    Trust Bio-sonics, Inc. · Cardiac Diseases

  • NNZ-2591Phase 32 trials

    Neuren Pharmaceuticals Limited · Phelan-McDermid Syndrome

  • NomlabofuspCTI-1601Phase 32 trials

    Larimar Therapeutics, Inc. · Friedreich Ataxia, Friedreich's Ataxia

NewerPage 16 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.